Novartis launches new campaign to raise awareness of multiple sclerosis

Novartis is joining the global multiple sclerosis (MS) community in celebration of World MS Day by launching a new campaign and participating in initiatives that encourage information and experience exchange around MS. Novartis is committed to supporting the MS community through these initiatives, in addition to delivering and researching innovative treatments to help address the high unmet medical needs of people with MS at every stage of the disease.

World MS Day was created by the Multiple Sclerosis International Foundation (MSIF) in 2009 to raise global awareness of MS and its impact on approximately 2.5 million people with MS around the world. This year’s World MS Day campaign focuses on young people; MS is normally diagnosed between the ages of 20 and 40, but can also occur earlier in life. This diagnosis can be devastating at a time when young people may be starting careers and making plans for the future.

Read More